Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by SSM0006on Dec 20, 2016 8:19am

27 Views

Post# 25623325

RE:RE:RE:RE:RE:Why is the CEO dumping shares?

As the NR said, he did it for tax purposes and to fund back the issuer. So, I would think in the New Year after taxes are filed, the cash should flow back into the company.

cylonninja wrote: It is very cool of him to sell his personal shares to raise money. Do you know when he is going to donate that money back to the company?

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario